Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1980 1
1981 1
1982 1
1983 1
1984 2
1985 5
1986 13
1987 10
1988 21
1989 20
1990 15
1991 16
1992 14
1993 7
1994 9
1995 7
1996 10
1997 10
1998 1
1999 4
2000 4
2001 1
2002 3
2003 2
2004 8
2005 5
2006 6
2007 4
2008 9
2009 14
2010 25
2011 45
2012 51
2013 40
2014 62
2015 42
2016 40
2017 52
2018 46
2019 51
2020 50
2021 91
2022 83
2023 76
2024 65
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

959 results

Results by year

Filters applied: . Clear all
Page 1
Dengue vaccine: an update.
Huang CH, Tsai YT, Wang SF, Wang WH, Chen YH. Huang CH, et al. Among authors: tsai yt. Expert Rev Anti Infect Ther. 2021 Dec;19(12):1495-1502. doi: 10.1080/14787210.2021.1949983. Epub 2021 Jul 13. Expert Rev Anti Infect Ther. 2021. PMID: 34182875 Review.
Targeted therapy in glomerular diseases.
Lin YC, Gau TS, Jiang ZH, Chen KY, Tsai YT, Lin KY, Tung HN, Chang FC. Lin YC, et al. Among authors: tsai yt. J Formos Med Assoc. 2024 Feb;123(2):149-158. doi: 10.1016/j.jfma.2023.06.020. Epub 2023 Jul 11. J Formos Med Assoc. 2024. PMID: 37442744 Free article. Review.
A T cell receptor β chain-directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity.
Hsu J, Donahue RN, Katragadda M, Lowry J, Huang W, Srinivasan K, Guntas G, Tang J, Servattalab R, Moisan J, Tsai YT, Stoop A, Palakurthi S, Chopra R, Liu K, Wherry EJ, Su Z, Gulley JL, Bayliffe A, Schlom J. Hsu J, et al. Among authors: tsai yt. Sci Transl Med. 2023 Nov 29;15(724):eadi0258. doi: 10.1126/scitranslmed.adi0258. Epub 2023 Nov 29. Sci Transl Med. 2023. PMID: 38019931 Free PMC article.
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer.
Rajan A, Abdul Sater H, Rahma O, Agajanian R, Lassoued W, Marté JL, Tsai YT, Donahue RN, Lamping E, Bailey S, Weisman A, Walter-Rodriguez B, Ito R, Vugmeyster Y, Sato M, Machl A, Schlom J, Gulley JL. Rajan A, et al. Among authors: tsai yt. J Immunother Cancer. 2024 Mar 13;12(3):e008480. doi: 10.1136/jitc-2023-008480. J Immunother Cancer. 2024. PMID: 38485188 Free PMC article. Clinical Trial.
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma.
Strauss J, Deville JL, Sznol M, Ravaud A, Maruzzo M, Pachynski RK, Gourdin TS, Maio M, Dirix L, Schlom J, Donahue RN, Tsai YT, Wang X, Vugmeyster Y, Beier F, Seebeck J, Schroeder A, Chennoufi S, Gulley JL. Strauss J, et al. Among authors: tsai yt. J Immunother Cancer. 2023 May;11(5):e005813. doi: 10.1136/jitc-2022-005813. J Immunother Cancer. 2023. PMID: 37236636 Free PMC article. Clinical Trial.
959 results